CASP3 and cholangiocarcinoma: Furthermore, in vitro experiments of Gemcitabine and PDT showed that cholangiocarcinoma induces repressing cell viability, apoptosis, and eliciting of CCA in G1 phase via modulating cyclin D1 and caspase 3 cleavage.